Standard BioTools Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom | Outperform |
8
|
$1.39k | Buy/Sell | $1.21k | 11.97% | 11 | $645.19B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$585.03 | Buy/Sell | $591.94 | 5.98% | 1 | $225.52B |
| ROG | Roche Holding | Hold |
16
|
CHF232.10 | Buy/Sell | CHF307.83 | 17.41% | 9 | CHF187.39B |
| DHR | Danaher | Outperform |
10
|
$261.40 | Buy/Sell | $260.33 | 4.22% | 4 | $197.90B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.23 | Buy/Sell | $118.92 | 19.93% | 7 | $182.35B |
| SIE | Siemens | Outperform |
10
|
177.18€ | Buy/Sell | 178.14€ | 10.62% | 11 | 136.14€B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$230.35 | Buy/Sell | $284.47 | 21.55% | 8 | $67.76B |
| A | Agilent Technologies | Outperform |
10
|
$150.55 | Buy/Sell | $138.82 | 0.30% | 10 | $44.80B |
| ILMN | Illumina | Outperform |
16
|
$105.85 | Buy/Sell | $159.28 | 39.35% | 9 | $17.10B |
| BIM | bioMérieux | Outperform |
18
|
94.70€ | Buy/Sell | 105.55€ | 21.44% | 1 | 11.73€B |
| TECH | Bio-Techne Corp | Buy |
16
|
$80.41 | Buy/Sell | $100.78 | 5.09% | 2 | $12.55B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$43.17 | Buy/Sell | $0.00 | 15.82% | 3 | $9.67B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$290.25 | Buy/Sell | $536.80 | 42.64% | 1 | $7.92B |
| TXG | 10x Genomics | Outperform |
6
|
$22.95 | Buy/Sell | $58.14 | 76.47% | 2 | $3.16B |
| QDEL | Quidel Corp | Hold |
16
|
$41.85 | Buy/Sell | $121.00 | 14.70% | 6 | $2.92B |
| CTKB | Cytek Biosciences | Outperform |
2
|
$5.92 | Buy/Sell | $10.00 | 68.92% | 1 | $813.84M |
| NSTG | NanoString Technologies | - |
7
|
$0.09 | Buy/Sell | $5.02 | -44.44% | 4 | $6.98M |
| NVTA | Invitae | - |
4
|
$0.00 | Buy/Sell | $0.71 | 0.00% | 8 | $3.18M |